Sienna Biopharmaceuticals, Inc. (18)
Browse by Contract Category
Contracts
-
Separation and General Release Agreement by and between Sienna Biopharmaceuticals, Inc. and Diane Stroehmann, dated as of August 1, 2019
(Filed With SEC on November 12, 2019)
-
Underwriting Agreement, dated as of February 20, 2019, among Sienna Biopharmaceuticals, Inc., Cowen and Company, LLC and BMO Capital Markets Corp., as representative of the...
(Filed With SEC on February 22, 2019)
-
Management Retention Plan Letter by and between Sienna Biopharmaceuticals, Inc. and Paul Lizzul, dated as of September 11, 2019
(Filed With SEC on November 12, 2019)
-
Key Employee Retention Plan
(Filed With SEC on November 12, 2019)
-
Key Employee Incentive Bonus Plan Letter by and between Sienna Biopharmaceuticals, Inc. and Timothy K. Andrews, dated as of September 11, 2019
(Filed With SEC on November 12, 2019)
-
Key Employee Incentive Bonus Plan Letter by and between Sienna Biopharmaceuticals, Inc. and Paul Lizzul, dated as of September 11, 2019
(Filed With SEC on November 12, 2019)
-
Key Employee Incentive Bonus Plan Letter by and between Sienna Biopharmaceuticals, Inc. and Alexander Azoy, dated as of September 11, 2019
(Filed With SEC on November 12, 2019)
-
Key Employee Incentive Bonus Plan Letter by and between Sienna Biopharmaceuticals, Inc. and Frederick C. Beddingfield III, dated as of September 11, 2019
(Filed With SEC on November 12, 2019)
-
Management Retention Plan Letter by and between Sienna Biopharmaceuticals, Inc. and Timothy K. Andrews, dated as of September 11, 2019
(Filed With SEC on November 12, 2019)
-
Management Retention Plan Letter by and between Sienna Biopharmaceuticals, Inc. and Alexander Azoy, dated as of September 11, 2019
(Filed With SEC on November 12, 2019)
-
Management Retention Plan Letter by and between Sienna Biopharmaceuticals, Inc. and Frederick C. Beddingfield III, dated as of September 11, 2019
(Filed With SEC on November 12, 2019)
-
Non-Employee Director Compensation Program, as amended and restated effective May 30, 2019
(Filed With SEC on August 8, 2019)
-
Separation and General Release Agreement by and between Sienna Biopharmaceuticals, Inc. and John W. Smither, dated as of April 1, 2019
(Filed With SEC on May 8, 2019)
-
Employment Agreement by and between Sienna Biopharmaceuticals, Inc. and Alexander Azoy, dated as of March 21, 2019
(Filed With SEC on May 8, 2019)
-
Separation Agreement by and between Sienna Biopharmaceuticals, Inc. and Todd Harris, dated as of November 5, 2018
(Filed With SEC on March 14, 2019)
-
Warrant to Purchase Common Stock, dated as of January 28, 2019, by and between Silicon Valley Bank and Sienna Biopharmaceuticals, Inc
(Filed With SEC on January 30, 2019)
-
First Amendment to Loan and Security Agreement, dated as of January 28, 2019 between Silicon Valley Bank and Sienna Biopharmaceuticals, Inc
(Filed With SEC on January 30, 2019)
-
Warrant to Purchase Common Stock, dated as of January 28, 2019, by and between Life Science Loans II, LLC and Sienna Biopharmaceuticals, Inc
(Filed With SEC on January 30, 2019)